Targeting HASPIN-mediated H3T3 phosphorylation disrupts an epigenetic-kinesin axis to suppress colorectal cancer

Tong Wu1, Yaguang Zhang1, Sicheng Liu1

  • 1Laboratory of Gastrointestinal Tumor Epigenetics and Genomics, State Key Laboratory of Biotherapy and Cancer Center, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, P.R. China.

Molecular Cancer
|July 7, 2026
PubMed

Insights

A new drug, CX6258.HCl, effectively inhibits colorectal cancer (CRC) growth by targeting the HASPIN pathway. This epigenetic approach suppresses mitosis and enhances chemotherapy, offering a promising new strategy for CRC treatment.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Chemoresistance is a significant challenge in colorectal cancer (CRC) treatment.
  • Epigenetic modifications play a crucial role in cancer progression and drug resistance.

Purpose of the Study:

  • To identify novel therapeutic targets and agents for colorectal cancer (CRC) by screening epigenetic compounds.
  • To investigate the mechanism of action of CX6258.HCl in inhibiting CRC growth and overcoming chemoresistance.

Main Methods:

  • Screening of epigenetic compounds using patient-derived organoids (PDOs).
  • In vitro studies on CRC cell lines to assess cytotoxicity, apoptosis, and cell cycle effects.
  • Mechanistic studies involving protein binding assays, Western blotting, and genetic validation (HASPIN-D687A mutation).
  • In vivo studies using CRC xenograft models and combination therapy with 5-FU.
  • Clinical correlation analysis of H3T3ph levels in human CRC tissues.

Main Results:

  • CX6258.HCl identified as a potent inhibitor of CRC cell growth, inducing apoptosis and mitotic arrest.
  • CX6258.HCl targets HASPIN at the D687 residue, suppressing H3T3 phosphorylation (H3T3ph).
  • This leads to KDM5B upregulation, H3K4me3 depletion, and disruption of microtubule dynamics via KIFs.
  • CX6258.HCl demonstrated efficacy in vivo, suppressing xenograft growth and potentiating 5-FU therapy.
  • Elevated H3T3ph levels correlate with tumor proliferation (Ki67) in human CRC.

Conclusions:

  • The HASPIN/H3T3ph-KDM5B-H3K4me3-KIF axis represents a novel, targetable antimitotic pathway in CRC.
  • Therapeutic inhibition of HASPIN/H3T3ph is a potential strategy for overcoming CRC chemoresistance.
  • H3T3ph may serve as a predictive biomarker for tumor proliferation in CRC.

Related Concept Videos

Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...